Why the study?
Does exercise preconditioning mitigate doxorubicin-induced cardiotoxicity without affecting its anti-neoplastic efficacy in a tumor-bearing murine model?
Does exercise preconditioning mitigate doxorubicin-induced cardiotoxicity without affecting its anti-neoplastic efficacy in a tumor-bearing murine model?
Exercise preconditioning in a murine model mitigates doxorubicin-induced cardiotoxicity without compromising its anti-tumor efficacy.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for exercise preconditioning in doxorubicin-treated patients; prospective trials needed before clinical adoption.
Cardiotoxicity associated with doxorubicin (DOX) is of primary concern during clinical therapy. Previous studies have shown that exercise preconditioning attenuates DOX-induced cardiac dysfunction in the murine non-tumor bearing model. Conversely, little is known regarding the effectiveness of exercise in tumor bearing animals. Exercise preconditioning may play an important role in attenuating both cardiotoxicity and tumor proliferation. PURPOSE: To investigate the effects of exercise preconditioning on the anti-neoplastic efficacy of DOX. Secondarily, to determine if DOX efficacy is unadulterated, can cardioprotection still be afforded by exercise. METHODS: Eight week old C57BL/6 (B6) male mice were randomly assigned to sedentary (SED, n=35) or treadmill exercise (TM, n=9) groups. After two weeks of exercise training (5d/wk, 1 hr/day), animals received a subcutaneous injection of either 5x105 cells of B16F10 (SED+Tumor, n=19 or TM+Tumor, n=9) or an equivalent volume of saline (SED+Nontumor, n=16). Three weeks following the tumor injection, animal received either 12 mg/kg of DOX (SED+Nontumor+DOX, n=8; SED+Tumor+DOX, n=10; TM+Tumor+DOX, n=9) or an equivalent volume of saline (Control, n=8; or SED+Tumor+SAL). Ten days after completing DOX treatment, cardiac function was assessed via echocardiography. RESULTS: DOX treatment resulted in a significant reduction in tumor growth (SED+Tumor+DOX, 3.9±3.9g; SED+Tumor+SAL, 10.7±6.7g; p<0.05). DOX treatment in SED+Tumor resulted in reduced mitral flow velocity MV (544±107mm/s) and aortic velocity AV (395±83mm/s) and increased isovolumic relaxation time IVRT (36.6±25.9ms) when compared to the control group (p<0.05). However, TM+Tumor+DOX AV (455±83mm/s) and IVRT (25.92+2.6ms) were not significantly different from the control (p>0.05). CONCLUSIONS: DOX reduced tumor growth in a tumor bearing murine model. Treadmill exercise preconditioning mitigated cardiac dysfunction induced by DOX, however, the anti-neoplastic efficacy was maintained.
No takes yet. Share an insight, caveat, or question.
Lien et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: